单位：[1]LungenClinic Grosshansdorf GmbH and Christian- Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany,[2]Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, United States,[3]Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, United States,[4]National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China,[5]Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester, United Kingdom,[6]National Heart and Lung Institute, Imperial College London, London, United Kingdom,[7]AstraZeneca, Durham, NC, United States,[8]AstraZeneca, Morristown, NJ, United States,[9]AstraZeneca, Gaithersburg, MD, United States, 10AstraZeneca, Gothenburg, Sweden.
第一作者单位：[1]LungenClinic Grosshansdorf GmbH and Christian- Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany,
推荐引用方式(GB/T 7714)：
K. F. Rabe,F. J. Martinez,G. T. Ferguson,et al.Single-Inhaler Triple Combination Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) at Two Corticosteroid Dose Levels in COPD: ETHOS Trial[J].AMERICAN JOURNAL of RESPIRATORY and CRITICAL CARE MEDICINE.2020,201:
APA：
K. F. Rabe,F. J. Martinez,G. T. Ferguson,C. Wang,D. Singh...&P. Dorinsky.(2020).Single-Inhaler Triple Combination Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) at Two Corticosteroid Dose Levels in COPD: ETHOS Trial.AMERICAN JOURNAL of RESPIRATORY and CRITICAL CARE MEDICINE,201,
MLA：
K. F. Rabe,et al."Single-Inhaler Triple Combination Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) at Two Corticosteroid Dose Levels in COPD: ETHOS Trial".AMERICAN JOURNAL of RESPIRATORY and CRITICAL CARE MEDICINE 201.(2020)
医学